On June 2, 2015, Irwin (Ernie) Rose died quietly in his sleep at age 88, after a long and fruitful lifetime of sleuthing for the secrets of life at the molecular level. Truly great scientists are much more than the sum of their publications and awards. This is especially true for Ernie who, when informed that he had been awarded the 2004 Nobel Prize in Chemistry, wondered aloud whether he really needed to go to Sweden to receive this honor. Although he did attend the ceremonies, and appeared to enjoy the process enormously, Ernie's eye was always on the biggest prize of all: understanding how Nature works.
Ernie was born in Brooklyn, New York but relocated with his family to Spokane, Washington when he was 13 years old. This move was dictated by the poor health of one of his brothers and the recommendation of a high, dry climate to speed his recovery. Ernie proceeded to make his way through the Spokane public school system and later Washington State University. Although his family was unable to provide him much guidance regarding a research career in biomedical science, this seems not to have deterred him at all. Ernie's first major research success came as a graduate student at the University of Chicago, where he used the newly available C-14 radioisotope to show that deoxycytidine is produced from its ribonucleoside precursor, cytidine. This important finding immediately implicated a new family of enzymes, the ribonucleotide reductases, in DNA synthesis. Given the degree of chemical and structural detail that Ernie would eventually bring to his research, it is remarkable that this early work was initiated before a 3D structure was available for either DNA or proteins. The ensuing mystery of how enzymes function, a "black box" in the 1950s, was to become a primary focus of Ernie's laser sharp intellect.
Ernie was my teacher. I first met him in 1968, when I joined his laboratory as a postdoctoral researcher. Ernie had become a member of the research staff at the Institute of Cancer Research (ICR) in Fox Chase, Philadelphia, five years earlier, and I was told "how very lucky I was to be able to work with him." Despite its name, the ICR was led by a forward-looking leader, Timothy Talbot, who recognized that success in biomedical research, cancer included, was ultimately dependent on the vigor of the underlying basic research. By the time I arrived at the ICR, a critical mass of fine researchers had been hired to pursue, among other things, enzyme structure and function. By 1970, the ICR was recognized as a magnet and training ground for anyone interested in this burgeoning research area.
Ernie's contributions to enzyme mechanisms represent some of his proudest accomplishments. His approach was straightforward and deceptively simple, especially in retrospect: How can one prove that enzymes use amino acid side chains to perform acid base chemistry? What is the origin of enzyme stereochemistry and its relationship to catalysis? How do enzymes "reset" themselves after each catalytic turnover? How can cryptic intermediates during enzyme turnover be detected and characterized? The nature of his solutions was anything but simple. For example, Ernie's demonstration of a role for an active site base in proton removal from an organic substrate came from the detection of an enzymes' ability to retain and transfer an atom of tritium from an initially labeled position in substrate to a different position in product. His pursuit of enzyme stereochemistry would reveal consistent patterns that could be directly related both to an evolutionary conservation of active site architecture and to a reaction mechanism. The detection of productive intermediates during enzyme turnover, an ongoing and difficult challenge, led to one of Ernie's most elegant contributions: that of positional isotope exchange (PIX). PIX, generally applicable to ATP-dependent reactions, involves labeling of ATP with O-18 in a bridge position and then monitoring the movement of the labeled oxygen to a nonbridged position within the unreacted pool of starting material. PIX introduced a completely nonperturbative probe for the reversibility of ATP hydrolysis at enzyme active sites, with relevance to many of the most complex enzyme machines found in biology.
In the course of his career, Ernie pursued many research interests that extended to the control of glycolysis and the role of ATP in cellular protein breakdown. The latter would ultimately lead to his Nobel Prize, demonstrating-at the molecular level-how proteins become tagged by ubiquitin as the signal for protein arrival at the proteasome and subsequent hydrolysis to small peptides. This discovery emerged from a fortuitous confluence of Ernie's longstanding interest in protein breakdown and a chance meeting with Avram Hershko, from Technion University, at a Fogerty Conference in Bethesda, Maryland. By 1977 Hershko and his student, Ciechanover, had uncovered a cellular factor in protein degradation (initially referred to as ATP-dependent proteolysis factor, APF-1). Annual visits to the ICR each summer by Hershko led to the mechanism of how APF-1 (renamed ubiquitin) undergoes enzymatic activation to become covalently attached to amino side chains within the protein targeted for degradation. The level of chemical intuition and sophistication that went into the unraveling of this complicated process is beautifully captured in a short retrospective by Ernie, published in 2005 (1).
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interaction. Our early meetings together were incredibly stressful for me, in the face of his unrelenting intensity toward science. At that time, I was a young mother, trying to balance an uncertain career in science with family. In the end, Ernie tolerated the time constraints imposed by my balancing act, while insisting on shaping me into a scientist of whom he could be proud. He must have seen some promise, because after two years as a postdoctoral associate he gave me the ultimate gift of financial support and a free pass to pursue my own diggings into the "black box" of the origins of enzyme catalysis. In later years, after I had moved to the University of California, Berkeley, Ernie and I became good friends, exchanging visits and sending our favorite books back and forth. His passion for science continued unabated, as he would try out thought experiments on how to solve one of his major and still unsolved interests: the origin of chirality in living systems. During this period, I also became friends with his son Bob, who was a postdoctoral fellow with Tom Alber at the University of California, Berkeley. Just two months before Ernie died, he and his son Fred gave me the gift of traveling from Western Massachusetts to attend my American Society for Biochemistry and Molecular Biology Mildred Cohn Award Lecture in Boston. I am deeply indebted for this last visit, although my deepest debt to Ernie has to be the gift of having one of the great scientific intellects of the 20th century as a teacher. 
